Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-4-15
pubmed:abstractText
Orthostatic hypotension has been observed when PDE 5 (cGMP-specific phosphodiesterase type 5) inhibitors are co-administered with alpha-adrenoceptor antagonists. Here we assessed the pharmacokinetic and haemodynamic interactions between udenafil and tamsulosin in rats, as both drugs are metabolized via rat hepatic cytochrome P450 3A1/2.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-11512128, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-13093635, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-14603504, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-15540759, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-15618743, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-15801542, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-15828055, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-15886285, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-15979430, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-16937336, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-17351661, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-17958337, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-18204480, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-18318773, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-18697186, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-240655, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-731416, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-8730926, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-9344174, http://linkedlifedata.com/resource/pubmed/commentcorrection/19254278-9849639
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1476-5381
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
156
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1009-18
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19254278-Administration, Oral, pubmed-meshheading:19254278-Adrenergic alpha-Antagonists, pubmed-meshheading:19254278-Animals, pubmed-meshheading:19254278-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:19254278-Blood Pressure, pubmed-meshheading:19254278-Cytochrome P-450 CYP3A, pubmed-meshheading:19254278-Drug Antagonism, pubmed-meshheading:19254278-Humans, pubmed-meshheading:19254278-Infusions, Intravenous, pubmed-meshheading:19254278-Liver, pubmed-meshheading:19254278-Male, pubmed-meshheading:19254278-Membrane Proteins, pubmed-meshheading:19254278-Microsomes, Liver, pubmed-meshheading:19254278-Phosphodiesterase 5 Inhibitors, pubmed-meshheading:19254278-Pyrimidines, pubmed-meshheading:19254278-Rats, pubmed-meshheading:19254278-Rats, Sprague-Dawley, pubmed-meshheading:19254278-Sulfonamides
pubmed:year
2009
pubmed:articleTitle
Interaction between udenafil and tamsulosin in rats: non-competitive inhibition of tamsulosin metabolism by udenafil via hepatic CYP3A1/2.
pubmed:affiliation
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, South Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't